Durvalumab vs Potassium Nitrate

## Durvalumab vs Potassium Nitrate: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Potassium Nitrate**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Potassium Nitrate — N/A.

## Chemical Properties

**Type**: Durvalumab — Antibody; Potassium Nitrate — Small molecule.